146 related articles for article (PubMed ID: 24412213)
41. IFN-γ Producing Th1 Cells Induce Different Transcriptional Profiles in Microglia and Astrocytes.
Prajeeth CK; Dittrich-Breiholz O; Talbot SR; Robert PA; Huehn J; Stangel M
Front Cell Neurosci; 2018; 12():352. PubMed ID: 30364000
[TBL] [Abstract][Full Text] [Related]
42. T-cell clones from Th1, Th17 or Th1/17 lineages and their signature cytokines have different capacity to activate endothelial cells or synoviocytes.
Lavocat F; Maggi L; Annunziato F; Miossec P
Cytokine; 2016 Dec; 88():241-250. PubMed ID: 27693917
[TBL] [Abstract][Full Text] [Related]
43. The immunobiology of colitis and cholangitis in interleukin-23p19 and interleukin-17A deleted dominant negative form of transforming growth factor beta receptor type II mice.
Ando Y; Yang GX; Tsuda M; Kawata K; Zhang W; Nakajima T; Tsuneyama K; Leung P; Lian ZX; Okazaki K; Ridgway WM; Norman GL; Ansari AA; He XS; Coppel RL; Gershwin ME
Hepatology; 2012 Oct; 56(4):1418-26. PubMed ID: 22532156
[TBL] [Abstract][Full Text] [Related]
44. IL-17A-producing T cells and associated cytokines are involved in the progression of gastric cancer.
Zhong F; Cui D; Tao H; Du H; Xing C
Oncol Rep; 2015 Nov; 34(5):2365-74. PubMed ID: 26352729
[TBL] [Abstract][Full Text] [Related]
45. Th1 and Th17 Immune Responses Act Complementarily to Optimally Control Superficial Dermatophytosis.
Heinen MP; Cambier L; Antoine N; Gabriel A; Gillet L; Bureau F; Mignon B
J Invest Dermatol; 2019 Mar; 139(3):626-637. PubMed ID: 30227138
[TBL] [Abstract][Full Text] [Related]
46. Development of a unique epigenetic signature during in vivo Th17 differentiation.
Yang BH; Floess S; Hagemann S; Deyneko IV; Groebe L; Pezoldt J; Sparwasser T; Lochner M; Huehn J
Nucleic Acids Res; 2015 Feb; 43(3):1537-48. PubMed ID: 25593324
[TBL] [Abstract][Full Text] [Related]
47. Adoptive transfer of Th1-conditioned lymphocytes promotes axonal remodeling and functional recovery after spinal cord injury.
Ishii H; Jin X; Ueno M; Tanabe S; Kubo T; Serada S; Naka T; Yamashita T
Cell Death Dis; 2012 Aug; 3(8):e363. PubMed ID: 22875000
[TBL] [Abstract][Full Text] [Related]
48. Neonatal neutrophils stimulated by group B Streptococcus induce a proinflammatory T-helper cell bias.
Lin J; Haridas S; Barenkamp SJ; Lorenset LC; Lee ASE; Schroeder BT; Peng G; Koenig JM
Pediatr Res; 2018 Mar; 83(3):739-746. PubMed ID: 29211057
[TBL] [Abstract][Full Text] [Related]
49. Th17 cells in depression.
Beurel E; Lowell JA
Brain Behav Immun; 2018 Mar; 69():28-34. PubMed ID: 28779999
[TBL] [Abstract][Full Text] [Related]
50. Th1 and Th17 cells: adversaries and collaborators.
Damsker JM; Hansen AM; Caspi RR
Ann N Y Acad Sci; 2010 Jan; 1183():211-21. PubMed ID: 20146717
[TBL] [Abstract][Full Text] [Related]
51. Suppressive effect of therapeutic antibiotic regimen on antipneumococcal Th1/Th17 responses in neonatal mice.
Shekhar S; Brar NK; Petersen FC
Pediatr Res; 2023 Mar; 93(4):818-826. PubMed ID: 35778498
[TBL] [Abstract][Full Text] [Related]
52. Interleukin-25 reduces Th17 cells and inflammatory responses in human peripheral blood mononuclear cells.
Mantani PT; Vallejo J; Ljungcrantz I; Nilsson J; Björkbacka H; Fredrikson GN
Hum Immunol; 2018 Sep; 79(9):685-692. PubMed ID: 29966691
[TBL] [Abstract][Full Text] [Related]
53. Th17 cells are long lived and retain a stem cell-like molecular signature.
Muranski P; Borman ZA; Kerkar SP; Klebanoff CA; Ji Y; Sanchez-Perez L; Sukumar M; Reger RN; Yu Z; Kern SJ; Roychoudhuri R; Ferreyra GA; Shen W; Durum SK; Feigenbaum L; Palmer DC; Antony PA; Chan CC; Laurence A; Danner RL; Gattinoni L; Restifo NP
Immunity; 2011 Dec; 35(6):972-85. PubMed ID: 22177921
[TBL] [Abstract][Full Text] [Related]
54. The role of interleukin-17 in immune-mediated inflammatory myopathies and possible therapeutic implications.
Moran EM; Mastaglia FL
Neuromuscul Disord; 2014 Nov; 24(11):943-52. PubMed ID: 25052503
[TBL] [Abstract][Full Text] [Related]
55. Can immunological manipulation defeat SARS-CoV-2? Why G-CSF induced neutrophil expansion is worth a clinical trial: G-CSF treatment against COVID-19.
Katayama H
Bioessays; 2021 Feb; 43(2):e2000232. PubMed ID: 33166093
[TBL] [Abstract][Full Text] [Related]
56. Defining the functional states of Th17 cells.
Lee Y; Kuchroo V
F1000Res; 2015; 4(F1000 Faculty Rev):132. PubMed ID: 27006754
[TBL] [Abstract][Full Text] [Related]
57. Th1 and Th17 cells regulate innate immune responses and bacterial clearance during central nervous system infection.
Holley MM; Kielian T
J Immunol; 2012 Feb; 188(3):1360-70. PubMed ID: 22190181
[TBL] [Abstract][Full Text] [Related]
58. Molecular and Morphological Characterization of Inflammatory Infiltrate in Rosacea Reveals Activation of Th1/Th17 Pathways.
Buhl T; Sulk M; Nowak P; Buddenkotte J; McDonald I; Aubert J; Carlavan I; Déret S; Reiniche P; Rivier M; Voegel JJ; Steinhoff M
J Invest Dermatol; 2015 Sep; 135(9):2198-2208. PubMed ID: 25848978
[TBL] [Abstract][Full Text] [Related]
59. IL-17A is not a treatment target in progressive vitiligo.
Speeckaert R; Mylle S; van Geel N
Pigment Cell Melanoma Res; 2019 Nov; 32(6):842-847. PubMed ID: 31063266
[TBL] [Abstract][Full Text] [Related]
60. The presence of IL-17A and T helper 17 cells in experimental mouse brain tumors and human glioma.
Wainwright DA; Sengupta S; Han Y; Ulasov IV; Lesniak MS
PLoS One; 2010 Oct; 5(10):e15390. PubMed ID: 21060663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
